TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33684598

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 min over the primary motor cortex and contralateral supraorbital area)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 104
Study: 36102853

Group type: EXPERIMENTAL
Intervention: Phenolization of the sinus tract(s)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radical excision with primary wound closure
Number of subjects: 100
Study: 36067977

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 32917925

Group type: EXPERIMENTAL
Intervention: Iron replacement therapy (oral or intravenous)
Number of subjects: 96724

Group type: EXPERIMENTAL
Intervention: Biological assessments of iron status
Number of subjects: 96724
Study: 34419666

Group type: EXPERIMENTAL
Intervention: Cardioneuroablation (CNA) for VVS
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Patient selection criteria for CNA
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ablation strategy
Number of subjects: 118

Group type: COMPARATOR
Intervention: RCT design
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Primary outcome measure
Number of subjects: 118
Study: 35669989

Group type: EXPERIMENTAL
Intervention: CP + aerobic VGE
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: CP + breathing VGE
Number of subjects: 39

Group type: COMPARATOR
Intervention: CP (control group)
Number of subjects: 39
Study: 32898141

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Social Behaviour and Network Therapy (SBNT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 112
Study: 36408812

Group type: EXPERIMENTAL
Intervention: 3D kinematic bike fitting
Number of subjects: 162

Group type: COMPARATOR
Intervention: Qualitative‐based riding posture recommendations
Number of subjects: 162
Study: 34326046

Group type: EXPERIMENTAL
Intervention: Culturally competent systems intervention including three DVA training sessions from a GP educator and bilingual DVA advocate/educator, followed by 12 months of support for clinic staff and DVA affected women.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Routine DVA care with training in ethnicity and DVA data entry for comparison clinics.
Number of subjects: 28
Study: 35099988

Group type: EXPERIMENTAL
Intervention: Slower intravenous fluid bolus rates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Faster intravenous fluid bolus rates
Number of subjects: 0
Study: 33210279

Group type: EXPERIMENTAL
Intervention: Trisquel board game intervention program
Number of subjects: 0
Study: 33546038

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg/6 h for 2 days, 4 mg/8 h for 2 days, 2 mg/6 h for 2 days, 2 mg/8 h for 2 days, 1 mg/8 h for 2 days, 1 mg/12 h for 2 days)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 600
Study: 35835435

Group type: EXPERIMENTAL
Intervention: Superior Capsular Reconstruction (SCR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bridging Graft (BG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SCR
Number of subjects: 50

Group type: COMPARATOR
Intervention: BG
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SCR with intact grafts
Number of subjects: 50

Group type: COMPARATOR
Intervention: BG with intact grafts
Number of subjects: 50
Study: 32406111

Group type: EXPERIMENTAL
Intervention: Everolimus + reduced-exposure tacrolimus (EVR + rTAC)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Mycophenolate mofetil + standard-exposure tacrolimus (MMF + sTAC)
Number of subjects: 106
Study: 32936509

Group type: EXPERIMENTAL
Intervention: Individual expert predictions
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Aggregated expert predictions
Number of subjects: 137

Group type: COMPARATOR
Intervention: Prediction algorithms guessing 50%
Number of subjects: 137

Group type: COMPARATOR
Intervention: Prediction algorithms trained on base rates
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Individual experts and aggregated predictions
Number of subjects: 137
Study: 33067278

Group type: EXPERIMENTAL
Intervention: Pulmonary-based Qigong exercise
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Elastic band-based resistance exercise (RE)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combined pulmonary-based Qigong exercise and elastic band-based RE
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 108
Study: 35348642

Group type: EXPERIMENTAL
Intervention: Adjunct AF surgery
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control
Number of subjects: 352
Study: 34813490

Group type: EXPERIMENTAL
Intervention: Intervention video about sugar reduction narrated by a child (mean 1.99, SD 0.83)
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Child narrator (mean 1.99, SD 0.87)
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Physician narrator (mean 1.95, SD 0.79)
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Intervention videos
Number of subjects: 4013

Group type: COMPARATOR
Intervention: Placebo video about sunscreen (mean 1.76, SD 0.69)
Number of subjects: 4013

Group type: COMPARATOR
Intervention: Placebo video about earthquakes (mean 1.56, SD 0.63)
Number of subjects: 4013
Study: 33383112

Group type: EXPERIMENTAL
Intervention: Aloe Vera vaginal cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Estrogen vaginal cream
Number of subjects: 60
Study: 32442828

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 36399023

Group type: EXPERIMENTAL
Intervention: E4 15 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: E4 5 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: E4 10 mg
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 33245445

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) training
Number of subjects: 38

Group type: COMPARATOR
Intervention: Enhanced Standard of Care
Number of subjects: 38
Study: 32079327

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF; 8 h/d)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Extended feeding (EXF; 15 h/d)
Number of subjects: 11
Study: 36127651

Group type: EXPERIMENTAL
Intervention: 940 nm diode laser irradiation (0.5 W, 10 J/cm2, continuous-wave mode, 20 s)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25
Study: 33965257

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haemophilus influenzae type b conjugate vaccine (Hib)
Number of subjects: 0
Study: 32892187

Group type: EXPERIMENTAL
Intervention: Physiotherapy in outpatient specialist healthcare
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Physiotherapy in primary care
Number of subjects: 167

Group type: COMPARATOR
Intervention: Overall cohort treatment
Number of subjects: 167
Study: 36001131

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 101

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 101
Study: 33677476

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during stationary cycling sessions
Number of subjects: 12

Group type: COMPARATOR
Intervention: No Virtual Reality (control condition) during stationary cycling sessions
Number of subjects: 12
Study: 33159736

Group type: EXPERIMENTAL
Intervention: Hybrid simulation method (Group A)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional method (Group B)
Number of subjects: 73
Study: 35219377

Group type: EXPERIMENTAL
Intervention: 200 mg garadacimab
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 600 mg garadacimab
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33875266

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (50 EU)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (100 EU)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (150 EU)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 33948743

Group type: EXPERIMENTAL
Intervention: High Transparency AI Explanation
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: Low Transparency AI Explanation
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: Good AI Model
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: Weak AI Model
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: Agreement with AI predictions
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: Correctness of AI predictions
Number of subjects: 3423
Study: 32924086

Group type: EXPERIMENTAL
Intervention: Coping Power Programme (CPP) added to Parent Management Training (PMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Parent Management Training (PMT) only
Number of subjects: 120
Study: 32502970

Group type: EXPERIMENTAL
Intervention: Lumbar spine manipulation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 3
Study: 616493118

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (0.3 g.kg‐1.d‐1 for 5 days followed by 0.1 g.kg‐1.d‐1 for 23 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 17
Study: 35467612

Group type: EXPERIMENTAL
Intervention: Positive rumination-based sports prescription (Experimental group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 61
Study: 33245002

Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone and metronidazole
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care (placebo)
Number of subjects: 50
Study: 35509491

Group type: EXPERIMENTAL
Intervention: IV midazolam and syrup (Group S)
Number of subjects: 180

Group type: COMPARATOR
Intervention: IV midazolam and water (Group C)
Number of subjects: 180
Study: 34531205

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (2 ?g/kg bolus, 1 ?g/kg/hour infusion up to 3 ?g/kg/hour)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.5 mg/kg bolus, intermittent bolus doses up to 2 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Revised regimen of intravenous fentanyl (2 ?g/kg bolus, 2 ?g/kg/hour infusion up to 5 ?g/kg/hour)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Revised regimen of intravenous ketamine (1 mg/kg bolus, intermittent bolus doses up to 4 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (revised regimen)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (revised regimen)
Number of subjects: 97
Study: 33351197

Group type: EXPERIMENTAL
Intervention: Lidocaine + Propofol (L + P)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal Saline + Propofol (NS + P)
Number of subjects: 48
Study: 35288320

Group type: EXPERIMENTAL
Intervention: Mechanical debridement (MD) followed by a single session of antimicrobial photodynamic therapy (aPDT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mechanical debridement (MD) alone
Number of subjects: 34
Study: 32289619

Group type: COMPARATOR
Intervention: Statin treatment
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Diabetes status
Number of subjects: 1998

Group type: EXPERIMENTAL
Intervention: High serum OPG levels
Number of subjects: 1998

Group type: EXPERIMENTAL
Intervention: Adjustment for standard predictors
Number of subjects: 1998
Study: 33905680

Group type: EXPERIMENTAL
Intervention: Early administration of antibiotics in a prehospital setting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early administration of antibiotics
Number of subjects: 0
Study: 32474920

Group type: EXPERIMENTAL
Intervention: Serum uric acid (UA) levels
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: SNP rs1165196 on SLC17A1
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Weighted genetic risk score (wGRS)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis for SNP rs1165196
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis for wGRS
Number of subjects: 633
Study: 35366329

Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet
Number of subjects: 48
Study: 33895733

Group type: EXPERIMENTAL
Intervention: PA (Physical Activity) intervention
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: DIET (Dietary) intervention
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PA + DIET intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (usual care plus education about PA and healthy eating)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All interventions (PA, DIET, PA + DIET, Control)
Number of subjects: 80
Study: 32131790

Group type: EXPERIMENTAL
Intervention: Educational program based on health belief model (HBM), 4 sessions in 1 month
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 33522376

Group type: EXPERIMENTAL
Intervention: Ketamine co-administered with sodium nitroprusside
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ketamine co-administered with placebo
Number of subjects: 16
Study: 32846174

Group type: EXPERIMENTAL
Intervention: Real 900 MHz RF‐EMF exposure for 26 min
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham exposure for 26 min
Number of subjects: 26
Study: 36303192

Group type: EXPERIMENTAL
Intervention: Single vocal cord irradiation (SVCI)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Transoral CO2-laser microsurgical cordectomy (TLM)
Number of subjects: 34
Study: 34802788

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (28,000 IU orally weekly for a maximum of 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (vaccinated immediately after randomization)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 40
Study: 35857076

Group type: EXPERIMENTAL
Intervention: Micro-hand robot-assisted cholecystectomy (MRC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: da Vinci robot-assisted cholecystectomy (DRC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Micro-hand robot-assisted cholecystectomy (MRC) and da Vinci robot-assisted cholecystectomy (DRC)
Number of subjects: 166
Study: 34252155

Group type: EXPERIMENTAL
Intervention: DNA methylation at locus cg03584380
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: DNA methylation at loci cg00076998, cg16758041, cg02365967
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Locus cg03584380
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Modules of loci
Number of subjects: 180
Study: 32556204

Group type: EXPERIMENTAL
Intervention: Undercooled liquid emulsion (LE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Partially crystalline solid emulsion (SE)
Number of subjects: 15
Study: 36189723

Group type: EXPERIMENTAL
Intervention: Mobile health intervention for cardiovascular health promotion
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Enrolled churches
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-enrolled churches
Number of subjects: 26
Study: 33797949

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.75 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32401189

Group type: EXPERIMENTAL
Intervention: Traditional null hypothesis significance testing (NHST)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Randomization/permutation inference
Number of subjects: 90
Study: 35767044

Group type: EXPERIMENTAL
Intervention: Experimental bioactive pastes containing niobophosphate (NbG) and 45S5 glasses at concentrations of 10%, 20%, or 30%.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo paste without bioactive glass.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Commercial paste (Nano P, FGM).
Number of subjects: 40
Study: 33797501

Group type: EXPERIMENTAL
Intervention: VTE patients
Number of subjects: 558

Group type: COMPARATOR
Intervention: Non-VTE patients
Number of subjects: 558
Study: 32955967

Group type: EXPERIMENTAL
Intervention: Reproxalap 0.5% ophthalmic solution (4 times daily for 6 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prednisolone 1% ophthalmic solution (Pred Forte®, 4 times daily taper for 6 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of reproxalap 0.5% ophthalmic solution (4 times daily for 6 weeks) and prednisolone 1% ophthalmic solution (twice daily taper for 6 weeks)
Number of subjects: 45
Study: 34958980

Group type: EXPERIMENTAL
Intervention: Animated DBT skills videos for 14 successive days (n = 99)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (n = 54)
Number of subjects: 153
Study: 34703529

Group type: EXPERIMENTAL
Intervention: Haloperidol 2.5 mg/day with methadone (LD group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg/day with methadone (HD group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo with methadone (LD and HD groups)
Number of subjects: 52
Study: 35321859

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 213
Study: 33225584

Group type: EXPERIMENTAL
Intervention: EMDRp + Treatment as Usual (TAU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 60
Study: 33279827

Group type: EXPERIMENTAL
Intervention: Imitation group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overimitation group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overimitation video
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age comparison
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline control groups
Number of subjects: 0
Study: 34516666

Group type: EXPERIMENTAL
Intervention: Darifenacin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mirabegron
Number of subjects: 60
Study: 33788481

Group type: EXPERIMENTAL
Intervention: Magnetic beads auricular point sticking therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (epidural labor analgesia only)
Number of subjects: 160
Study: 36083488

Group type: EXPERIMENTAL
Intervention: Wenshen Jianpi recipe (WJR) combined with antiretroviral therapy (ART)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 56
Study: 33409689

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (traditional procedures)
Number of subjects: 102
Study: 33839075

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 4796
Study: 33126310

Group type: EXPERIMENTAL
Intervention: DA‐5204 (Stillen 2X, 90 mg of Artemisia asiatica 95% ethanol extract per tablet) with pantoprazole 40 mg once daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo with pantoprazole 40 mg once daily
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: DA‐5204 (Stillen 2X) with pantoprazole 40 mg once daily
Number of subjects: 70
Study: 615917012

Group type: EXPERIMENTAL
Intervention: Patients who watched a video explaining the role of a surgical simulator in resident training (group one)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Patients who did not watch the video (group two)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Overall patient population
Number of subjects: 410
Study: 35619141

Group type: EXPERIMENTAL
Intervention: AFO with oil damper (AFO-OD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nonarticulated AFO
Number of subjects: 41
Study: 34874655

Group type: EXPERIMENTAL
Intervention: Phenosanic acid (Dibufelon)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35917650

Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg twice a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33518298

Group type: COMPARATOR
Intervention: Control diet (corn soy) with 0% WB or SBP
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 6% SBP diet
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 3% SBP diet
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 3% WB diet
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Xylanase supplementation (100 mg per kg)
Number of subjects: 540
Study: 35134913

Group type: EXPERIMENTAL
Intervention: Piano training
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Computer‐assisted cognitive training
Number of subjects: 155

Group type: COMPARATOR
Intervention: No‐treatment control
Number of subjects: 155
Study: 32979855

Group type: EXPERIMENTAL
Intervention: Glucose-with-insulin (GwI) infusions
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Lower pretreatment capillary blood glucose (CBG)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Diagnosis of type 2 diabetes
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Treatment for hyperkalaemia within the previous 24 hours
Number of subjects: 132
Study: 33035082

Group type: EXPERIMENTAL
Intervention: Cannabis (low-THC)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Alcohol (BrAC approximately 0.05%)
Number of subjects: 6
Study: 34403424

Group type: EXPERIMENTAL
Intervention: Community-based mass drug administration (MDA) with albendazole
Number of subjects: 6153
Study: 36094652

Group type: EXPERIMENTAL
Intervention: Closed-loop deep brain stimulation (DBS) therapy
Number of subjects: 4

Group type: COMPARATOR
Intervention: Conventional deep brain stimulation (DBS)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Closed-loop deep brain stimulation (DBS)
Number of subjects: 4
Study: 34143584

Group type: EXPERIMENTAL
Intervention: Bulk-fill material Admira Fusion x‐tra, applied with increments up to 4 mm
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular Admira Fusion, applied by a 2 mm layering technique
Number of subjects: 30
Study: 32896776

Group type: EXPERIMENTAL
Intervention: High-volume hospitals
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Surgeon volume
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation (CRT)
Number of subjects: 799